clinical trial · NCT07037277
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
HEPATITIS C VIRUS CHRONIC INFECTIONHepatitis C, ChronicHepatitis C Virus InfectionHepatitis CBemnifosbuvir-RuzasvirSofosbuvir-Velpatasvir
brief summary
The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.
started
Jun 2, 2025
primary completion
Dec 1, 2026
completion
Mar 1, 2027
last updated
Apr 13, 2026
official title
An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol